跳转至内容
Merck
所有图片(1)

Key Documents

444283

Sigma-Aldrich

MMP-13抑制剂

The MMP-13 Inhibitor, also referenced under CAS 544678-85-5, controls the biological activity of MMP-13. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.

别名:

MMP-13抑制剂, 嘧啶-4,6-二羧酸,-(4-氟-3-甲基-苄基酰胺)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C22H20F2N4O2
分子量:
410.42
分類程式碼代碼:
12352200
NACRES:
NA.77

品質等級

化驗

≥98% (HPLC)

形狀

solid

製造商/商標名

Calbiochem®

儲存條件

OK to freeze
protect from light

顏色

light yellow

溶解度

DMSO: 10 mg/mL

運輸包裝

ambient

儲存溫度

2-8°C

InChI

1S/C22H20F2N4O2/c1-13-7-15(3-5-17(13)23)10-25-21(29)19-9-20(28-12-27-19)22(30)26-11-16-4-6-18(24)14(2)8-16/h3-9,12H,10-11H2,1-2H3,(H,25,29)(H,26,30)

InChI 密鑰

PYFRREJCFXFNRR-UHFFFAOYSA-N

一般說明

MMP-13活性的强效抑制剂(IC50=8 nM),并通过构象结构分析确定对MMP-1,-2,-3,-7,-8,-9,-10,-12,-14和-16具有预期的选择性。显示与MMP-13催化结构域结合并充当非锌螯合抑制剂。
一种嘧啶二甲酰胺化合物,可有效抑制MMP-13活性(IC50=8 nM),并通过构象结构分析确定对MMP-1,-2,-3,-7,-8,-9,-10,-12,-14和-16具有预期的选择性。显示与MMP-13催化结构域结合并充当非锌螯合抑制剂。

生化/生理作用

主要靶标
MMP-13活性
产物不与ATP竞争。
可逆:否
细胞渗透性:否
靶标IC50:MMP-13为8 nM

包裝

用惰性气体包装

警告

毒性:标准处理(A)

準備報告

使用前立即用缓冲液进一步稀释。

重構

复溶后,等分并冷冻保存(-20°C)。贮备液在-20°C下可稳定保存至多6个月。

其他說明

Engel, C.K., et al. 2005.Chem. Biol.12, 181.

法律資訊

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Christian K Engel et al.
Chemistry & biology, 12(2), 181-189 (2005-03-01)
Inhibitors for matrix metalloproteinases (MMPs) are under investigation for the treatment of cancer, arthritis, and cardiovascular disease. Here, we report a class of highly selective MMP-13 inhibitors (pyrimidine dicarboxamides) that exhibit no detectable activity against other MMPs. The high-resolution X-ray
Spenser S Smith et al.
eLife, 11 (2022-06-07)
Precise developmental control of jaw length is critical for survival, but underlying molecular mechanisms remain poorly understood. The jaw skeleton arises from neural crest mesenchyme (NCM), and we previously demonstrated that these progenitor cells express more bone-resorbing enzymes including Matrix
Kristina Viiklepp et al.
The Journal of investigative dermatology (2021-11-11)
Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer with increasing incidence worldwide. Previous studies have demonstrated the role of complement system in cSCC progression. In this study we have investigated the mechanistic role of serine protease

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门